Single-Cell Transcriptomics Integrated with Targeted cis-Mendelian Randomization Identifies Candidate Targets for Osteoarthritis
Genes · 07.11.2026 · 17 (11) · 1406
DOI: 10.3390/genes17111406 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 07.11.2026. Verfasst von Yifei Wang und 3 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Scientific Research Foundation of Guangdong Province, China, Scientific Research Project of Guangdong Provincial Sports Bureau, Science and Technology Projects in Guangzhou.
Abstract (Originalsprache)
Background
Disease-modifying osteoarthritis drugs (DMOADs) remain an urgent, unmet clinical need. This study integrated single-cell transcriptomics (scRNA-seq), targeted cis-protein quantitative trait loci (cis-pQTL) Mendelian randomization (cis-MR), and Bayesian colocalization to identify and stratify genetically supported therapeutic targets for osteoarthritis (OA).
Methods
Human OA joint scRNA-seq profiles (GSE152805) were analyzed to delineate cellular subpopulations and marker genes. Two-sample cis-MR was performed using lead cis-pQTL instruments from deCODE Genetics and UK Biobank PPP against FinnGen OA GWAS summary statistics. Causal directionality was confirmed using Steiger filtering, and shared causal variants were assessed via Bayesian colocalization (coloc). Candidate targets were mapped to pharmacological databases for hypothesis-generating repurposing opportunities. Results: scRNA-seq delineated distinct cell populations, showing marked upregulation of THY1 and IL6 in inflammatory synovial fibroblasts, MMP13 in hypertrophic chondrocytes, and CDKN2A in senescent chondrocytes. cis-MR demonstrated that genetically predicted higher circulating levels of THY1 (MR Beta = 0.626, OR = 1.87, p = 1.76 × 10−7), CDKN2A (MR Beta = 0.432, OR = 1.54, p = 5.38 × 10−5), and MMP13 (MR Beta = 0.405, OR = 1.50, p = 4.33 × 10−5) were significantly associated with increased Knee OA risk; IL6 exhibited a suggestive association. Evidence stratification via colocalization confirmed strong shared causal variant support for the THY1 locus (PP.H4 = 91.2%), while CDKN2A and MMP13 exhibited inconclusive or merely suggestive colocalization. In silico mapping identified hypothesis-generating interventions, including potential Notch inhibitors for THY1 and senolytics targeting CDKN2A-associated senescent cell survival pathways.
Conclusions
Integrating single-cell resolution with cis-MR provides tiered human genetic evidence for OA pathogenesis. THY1 emerges as a robustly supported candidate target corroborated by both MR and strong colocalization, whereas CDKN2A and MMP13 currently lack sufficient colocalization support and require further fine-mapping. These findings offer a genetically informed framework for hypothesis-generating therapeutic development requiring future experimental confirmation.
Förderung
- Medical Scientific Research Foundation of Guangdong Province, China
- Scientific Research Project of Guangdong Provincial Sports Bureau
- Science and Technology Projects in Guangzhou
Zitieren
APA
Wang, Y., He, J., Zhuang, T., & Wu, W. (2026). Single-Cell Transcriptomics Integrated with Targeted cis-Mendelian Randomization Identifies Candidate Targets for Osteoarthritis. Genes, 17(11), 1406. https://doi.org/10.3390/genes17111406
Vancouver
Wang Y, He J, Zhuang T, Wu W. Single-Cell Transcriptomics Integrated with Targeted cis-Mendelian Randomization Identifies Candidate Targets for Osteoarthritis. Genes. 2026;17(11):1406. doi:10.3390/genes17111406
BibTeX
@article{Wang2026,
author = {Wang, Yifei and He, Jiaqing and Zhuang, Tengfeng and Wu, Wenrui},
title = {Single-Cell Transcriptomics Integrated with Targeted cis-Mendelian Randomization Identifies Candidate Targets for Osteoarthritis},
journal = {Genes},
year = {2026},
volume = {17},
number = {11},
pages = {1406},
doi = {10.3390/genes17111406}
}
EUVIMED